Barry D. Quart

Insider Reports History

Location
C/O Intrabiotics Pharmaceuticals Inc, 1009 Oak Hill Road, Suite 201, Lafayette, CA
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Barry D. Quart:

Insider Reports Filed by Barry D. Quart

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KNSA Kiniksa Pharmaceuticals International, plc Jun 9, 2025 9 -$729K 4 Jun 11, 2025 Director
KNSA Kiniksa Pharmaceuticals International, plc Jun 3, 2025 4 $0 4 Jun 5, 2025 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 5, 2024 4 $0 4 Jun 7, 2024 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2023 2 $0 4 Jul 3, 2023 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 6, 2023 2 $0 4 Jun 8, 2023 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Jan 18, 2023 1 $0 4 Jan 20, 2023 Chief Executive Officer, Director
HRTX HERON THERAPEUTICS, INC. /DE/ Jan 13, 2023 6 -$11.1K 4 Jan 17, 2023 Chief Executive Officer, Director
KNSA Kiniksa Pharmaceuticals, Ltd. Nov 29, 2022 3 -$320K 4 Dec 1, 2022 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Oct 13, 2022 5 -$19.6K 4 Oct 17, 2022 Chief Executive Officer, Director
HRTX HERON THERAPEUTICS, INC. /DE/ Jul 13, 2022 6 -$9.93K 4 Jul 15, 2022 Chief Executive Officer, Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2022 2 $0 4 Jun 30, 2022 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Apr 13, 2022 5 -$31.7K 4 Apr 15, 2022 Chief Executive Officer, Director
HRTX HERON THERAPEUTICS, INC. /DE/ Jan 13, 2022 5 -$43.3K 4 Jan 14, 2022 Chief Executive Officer, Director
HRTX HERON THERAPEUTICS, INC. /DE/ Oct 13, 2021 5 -$10.2K 4 Oct 15, 2021 Chief Executive Officer, Director
HRTX HERON THERAPEUTICS, INC. /DE/ Jul 13, 2021 4 $8.27K 4 Jul 15, 2021 Chief Executive Officer, Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2021 1 $0 4 Jun 30, 2021 Director